Runheng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Runheng Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Baoxin Huang
Hospital of Stomatology Sun Yat‐sen University Guangzhou China
1 shared publication - Guanqi Liu
Weihai Engineering Research Center of Graphite Deep-processing Technology, 2 West Wenhua Road, Weihai, 264209, China
1 shared publication - Hong Ai
Department of Stomatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
1 shared publication Jinying Lin
Xiamen Stomatological Hospital, Xiamen 361000, China
1 shared publicationLin Chen
Department of Stomatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
1 shared publicationLinjun Zhang
Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University and Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510055, China
1 shared publication
Latest Publications
- Open Access
- 4 April 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-13
Suppressing MicroRNA-30b by Estrogen Promotes Osteogenesis in Bone Marrow Mesenchymal Stem Cells
MicroRNAs (miRNAs) have been widely demonstrated to interact with multiple cellular signaling pathways and to participate in a wide range of physiological processes. Estradiol-17β(E2) is the most potent and prevalent endogenous estrogen that plays a vital role in promoting bone formation and reducing bone resorption. Currently, little is known about the regulation of miRNAs in E2-induced osteogenic differentiation. In the present study, the primary bone marrow mesenchymal stem cells from rats (rBMSCs) were isolated and incubated with E2, followed by miRNA profiling. The microarray showed that 29 miRNAs were differentially expressed in response to E2 stimulation. Further verification by real-time reverse-transcriptase polymerase chain reaction revealed that E2 enhanced the expression of let-7b and miR-25 but suppressed the miR-30b expression. Moreover, a gain-of-function experiment confirmed that miR-30b negatively regulated the E2-induced osteogenic differentiation. These data suggest an important role of miRNAs in osteogenic differentiation.
- 4 April 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-13
Open AccessSuppressing MicroRNA-30b by Estrogen Promotes Osteogenesis in Bone Marrow Mesenchymal Stem Cells
MicroRNAs (miRNAs) have been widely demonstrated to interact with multiple cellular signaling pathways and to participate in a wide range of physiological processes. Estradiol-17β(E2) is the most potent and prevalent endogenous estrogen that plays a vital role in promoting bone formation and reducing bone resorption. Currently, little is known about the regulation of miRNAs in E2-induced osteogenic differentiation. In the present study, the primary bone marrow mesenchymal stem cells from rats (rBMSCs) were isolated and incubated with E2, followed by miRNA profiling. The microarray showed that 29 miRNAs were differentially expressed in response to E2 stimulation. Further verification by real-time reverse-transcriptase polymerase chain reaction revealed that E2 enhanced the expression of let-7b and miR-25 but suppressed the miR-30b expression. Moreover, a gain-of-function experiment confirmed that miR-30b negatively regulated the E2-induced osteogenic differentiation. These data suggest an important role of miRNAs in osteogenic differentiation.
- 7 May 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (7) , 2516-2527
Blood Prefabrication Subcutaneous Small Animal Model for the Evaluation of Bone Substitute Materials
Due to the size of bone substitute material particles, large animal bone defect models are usually required for the assessment these materials. However, these models have such disadvantages as high costs, complicated operation procedures, ethical issues, and difficulties in sample analysis. In addition, to mimic the bone environment, conventional subcutaneous models require the addition of osteogenic factors and stem cells, resulting in an expensive model with a complex experimental procedure. To avoid these issues, in this study, we proposed a convenient and effective blood prefabrication subcutaneous small animal model that could be applied to assess bone substitute materials. Our results demonstrated that blood prefabrication could be an economical, convenient and useful “adhesive” for handling bone substitute particles. This process provided porcine hydroxyapatite (PHA) with a microenvironment enriched with mesenchymal stem cells and growth factors. Using this strategy, bone-like structure could form in a rat subcutaneous pocket. Furthermore, the optimized subcutaneous model was used to evaluate the PHA’s osteoinductivity, producing results similar to that of the calvarial bone defect in terms of osteogenesis, osteoclastogenesis and blood vessel formation. These results collectively imply that the blood prefabrication subcutaneous small animal model is convenient and effective for the assessment of the osteoinductivity of bone substitute materials.
- 7 May 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (7) , 2516-2527
Blood Prefabrication Subcutaneous Small Animal Model for the Evaluation of Bone Substitute Materials
Due to the size of bone substitute material particles, large animal bone defect models are usually required for the assessment these materials. However, these models have such disadvantages as high costs, complicated operation procedures, ethical issues, and difficulties in sample analysis. In addition, to mimic the bone environment, conventional subcutaneous models require the addition of osteogenic factors and stem cells, resulting in an expensive model with a complex experimental procedure. To avoid these issues, in this study, we proposed a convenient and effective blood prefabrication subcutaneous small animal model that could be applied to assess bone substitute materials. Our results demonstrated that blood prefabrication could be an economical, convenient and useful “adhesive” for handling bone substitute particles. This process provided porcine hydroxyapatite (PHA) with a microenvironment enriched with mesenchymal stem cells and growth factors. Using this strategy, bone-like structure could form in a rat subcutaneous pocket. Furthermore, the optimized subcutaneous model was used to evaluate the PHA’s osteoinductivity, producing results similar to that of the calvarial bone defect in terms of osteogenesis, osteoclastogenesis and blood vessel formation. These results collectively imply that the blood prefabrication subcutaneous small animal model is convenient and effective for the assessment of the osteoinductivity of bone substitute materials.